Biblio
Efficacy and safety of humanized anti-CD19-CAR-T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia. Br J Haematol. 2020.
. Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL. Ann Hematol. 2023.
Glutaredoxin 2 protects lens epithelial cells from epithelial-mesenchymal transition by suppressing mitochondrial oxidative stress-related upregulation of integrin-linked kinase. Exp Eye Res. 2023:109609.
. Humanized anti-CD19 CAR-T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved HBV infection. Hematol Oncol. 2020.
. . .